Medical scheme Gems experts to review decision on funding cancer drug Keytruda

Government medical scheme, Gems, has responded to allegations that it refused to pay for treatment for one of their clients who has stage four cancer.

Chief Operating Officer at Gems, Dr Stan Moloabi says the cancer treatment drug, Keytruda, which Dr Sipho Bvuma's oncologist recommended is not registered for specific cancer that Bvuma suffers from.

He says the medical scheme rules do not allow for funding of drugs that are not registered for specific ailments.

Read: Bara doctor takes medical aid to court for denying him 'pricey' cancer treatment

In this instance, there were two panels of experts who had to consider this request and both are panels of oncologists and they came to the conclusion that it will not be appropriate to fund this said treatment.

Dr Stan Moloabi, Chief Operating Officer at Gems

This is the second time that Gems denies payment of treatment for Bvuma. He says he initially took them to court and the court ruled in his favour.

He has approached the courts for the second time now for the funding of the drug Keytruda which he believes will prolong his life and move him into remission stage.

There are clinical decisions that are taken by the doctors that are treating and we need to separate them from funding decisions. This is a difficult concept but that is how funding is done.

Dr Stan Moloabi, Chief Operating Officer at Gems

The funding decision is based on the scheme rules...

Dr Stan Moloabi, Chief Operating Officer at Gems

If medication is not proven to work in that category, then Gems will not be acting responsibly to be funding something that is ultimately not going to work.

Dr Stan Moloabi, Chief Operating Officer at Gems

Moloabi says the latest update sees the court setting aside Bvuma's application to have Keytruda administered.

He says Gems panel of experts will again relook at the funding of Keytruda and make a decision because this is a "matter of life and death".

The lawyer representing Dr Sipho Bvuma, Linda Skhosana, denies that the court set aside the matter. He says that the court has referred the matter to the Council for Medical Schemes Appeal Board and if they are not satisfied with the outcome they should return to court.

To hear the rest of the conversation, listen below:


This article first appeared on 702 : Medical scheme Gems experts to review decision on funding cancer drug Keytruda


Recommended

by NEWSROOM AI
Read More
Medical students stand together to raise funds for disadvantaged peers

Medical students stand together to raise funds for disadvantaged peers

The students will be cycling 902 km to build a fund that will put an end to financial exclusion on campus.

Momentum to pay all violent crime claims, regardless of previous medical history

Momentum to pay all violent crime claims, regardless of previous medical history

The Money Show’s Bruce Whitfield interviews Johann le Roux, CEO at Momentum Life.

Life insurance 101: Mention every detail of your medical history - consumer guru

Life insurance 101: Mention every detail of your medical history - consumer guru

The saga involving insurer Momentum has many South Africans thinking twice about their current life insurance policies.

Bara doctor takes medical aid to court for denying him 'pricey' cancer treatment

Bara doctor takes medical aid to court for denying him 'pricey' cancer treatment

Dr Sipho Bvuma says Gems has refused to pay for his expensive brain cancer treatment, which he believes will prolong his life.

Momentum explains why it refused to pay shooting victim's life insurance

Momentum explains why it refused to pay shooting victim's life insurance

The insurer faces huge criticism over that decision, based it says on the fact that Nathan Ganas had high blood sugar levels.

Popular articles
How Stellenbosch became a breeding ground for Afrikaner billionaire businessmen

How Stellenbosch became a breeding ground for Afrikaner billionaire businessmen

The Money Show's Bruce Whitfield interviews Pieter du Toit, author of "The Stellenbosch Mafia: Inside the Billionaires' Club".

47% probability of the rand crashing in next 12 months - Rand Merchant Bank

47% probability of the rand crashing in next 12 months - Rand Merchant Bank

The writing is probably on the wall for the resurgent rand. Bruce Whitfield interviews John Cairns, a Strategist at RMB.

Outrage as pastor tells students gay people are 'as bad as Hitler'

Outrage as pastor tells students gay people are 'as bad as Hitler'

Students at De Kuilen High are being offered counselling after being told by Pickard Henn that gay people are going to hell.

For R17,000 you can get your UK visa application done in 24 hours

For R17,000 you can get your UK visa application done in 24 hours

Immigration consultancy Move Up managing director Ryan Rennison says the service is mostly used by senior executives.

'It's about time too!' DJ Fresh on his new 947 gig  #FreshOn947

'It's about time too!' DJ Fresh on his new 947 gig #FreshOn947

The news that DJ Fresh would be joining 947 was dominating on social media on Monday with the hashtag #Freshon97

Brand new business hub to help startups get off the ground  - CPT

Brand new business hub to help startups get off the ground - CPT

It's being dubbed a 'one-stop-shop' for entrepreneurs and startups looking for opportunities in the Mother City.

'A lot of people may have wanted him dead.'  - Who killed Mark Batchelor?

'A lot of people may have wanted him dead.' - Who killed Mark Batchelor?

A Sunday newspaper report has suggested the soccer ace's death may have been linked to a missing stash of cocaine.

Paying off your credit card every month to avoid interest? The banks are sneaky…

Paying off your credit card every month to avoid interest? The banks are sneaky…

Consumer journalist Wendy Knowler warns prudent credit card holders to keep tabs on their banks. In this case, it’s FNB.